Implementing a best-treatment strategywith intracoronary brachytherapy for in-stent restenosis in patients at high risk for recurrence^
|Full paper||Not Available|
The deployment of drug-eluting stems (DES) to heat bare-metal stem restenosis [in-stent restenosis (ISR)] has become routine practice, with a consequential decline in the use of inhacoronaiy brachytherapy (ICBT). However, them are concerns as to the long-term safety profile ofDES, particularly in terms of late stemthrombosis. In addition, an appropriate treatment strategy for stenosiswithinDEShas not been developed. The aimofthis studywas to examine the efficacy of best treatmentwith ICBT for ISR in patients at high risk for fiiture recurrence.